Interesting concept here....they own a big chunk of RVX for a buck, if they convert next week and we have a a block of time to find a buyer and do whatever trials that we need......am I right that buys us time until March 2020 (assuming the 3 MM per month burn rate) under this scenario?...can we get enough time for, say inflammation and kidney work by them to make the FDA happy?

More time if burn rate is slashed now that Phase III trials has finished Ed?